These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 1907825

  • 1. Pharmacology of the pyrroloimidazole, SK&F 105809--II. Antiinflammatory activity and inhibition of mediator production in vivo.
    Griswold DE, Marshall PJ, Lee JC, Webb EF, Hillegass LM, Wartell J, Newton J, Hanna N.
    Biochem Pharmacol; 1991 Jul 25; 42(4):825-31. PubMed ID: 1907825
    [Abstract] [Full Text] [Related]

  • 2. Pharmacology of the pyrroloimidazole, SK&F 105809--I. Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
    Marshall PJ, Griswold DE, Breton J, Webb EF, Hillegass LM, Sarau HM, Newton J, Lee JC, Bender PE, Hanna N.
    Biochem Pharmacol; 1991 Jul 25; 42(4):813-24. PubMed ID: 1907824
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological profile of SK&F 105809, a dual inhibitor of arachidonic acid metabolism.
    Hanna N, Marshall PJ, Newton J, Schwartz L, Kirsh R, Dimartino MJ, Adams J, Bender P, Griswold DE.
    Drugs Exp Clin Res; 1990 Jul 25; 16(4):137-47. PubMed ID: 2127565
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of inflammatory cell infiltration by bicyclic imidazoles, SK&F 86002 and SK&F 104493.
    Griswold DE, Hoffstein S, Marshall PJ, Webb EF, Hillegass L, Bender PE, Hanna N.
    Inflammation; 1989 Dec 25; 13(6):727-39. PubMed ID: 2559032
    [Abstract] [Full Text] [Related]

  • 5. SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
    Griswold DE, Marshall PJ, Webb EF, Godfrey R, Newton J, DiMartino MJ, Sarau HM, Gleason JG, Poste G, Hanna N.
    Biochem Pharmacol; 1987 Oct 15; 36(20):3463-70. PubMed ID: 2823821
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Analgetic activity of SK&F 105809, a dual inhibitor of arachidonic acid metabolism.
    Griswold DE, Marshall P, Martin L, Webb EF, Zabko-Potapovich B.
    Agents Actions Suppl; 1991 Oct 15; 32():113-7. PubMed ID: 1906235
    [Abstract] [Full Text] [Related]

  • 9. Pyridinyl imidazoles inhibit the inflammatory phase of delayed type hypersensitivity reactions without affecting T-dependent immune responses.
    Reddy MP, Webb EF, Cassatt D, Maley D, Lee JC, Griswold DE, Truneh A.
    Int J Immunopharmacol; 1994 Oct 15; 16(10):795-804. PubMed ID: 7843851
    [Abstract] [Full Text] [Related]

  • 10. 2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activity.
    Foster SJ, Bruneau P, Walker ER, McMillan RM.
    Br J Pharmacol; 1990 Jan 15; 99(1):113-8. PubMed ID: 2110012
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC, Ritchie DM, Ferro MP, Kirchner T, Wachter MP, Anderson DW, Rosenthale ME, Capetola RJ.
    J Pharmacol Exp Ther; 1994 Dec 15; 271(3):1399-408. PubMed ID: 7996452
    [Abstract] [Full Text] [Related]

  • 14. Cytokine suppressive anti-inflammatory compounds inhibit bone resorption in vitro.
    Votta BJ, Bertolini DR.
    Bone; 1994 Dec 15; 15(5):533-8. PubMed ID: 7980964
    [Abstract] [Full Text] [Related]

  • 15. Role of corticosterone in modulation of eicosanoid biosynthesis and antiinflammatory activity by 5-lipoxygenase (5-LO) and cyclooxygenase (CO) inhibitors.
    Tomchek LA, Hartman DA, Lewin AC, Calhoun W, Chau TT, Carlson RP.
    Agents Actions; 1991 Sep 15; 34(1-2):20-4. PubMed ID: 1665293
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the cutaneous anti-inflammatory activity of azaspiranes.
    Griswold DE, Martin LD, Badger AM, Breton J, Chabot-Fletcher M.
    Inflamm Res; 1998 Feb 15; 47(2):56-61. PubMed ID: 9535542
    [Abstract] [Full Text] [Related]

  • 17. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
    Rao NL, Dunford PJ, Xue X, Jiang X, Lundeen KA, Coles F, Riley JP, Williams KN, Grice CA, Edwards JP, Karlsson L, Fourie AM.
    J Pharmacol Exp Ther; 2007 Jun 15; 321(3):1154-60. PubMed ID: 17371808
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.
    Carlson RP, O'Neill-Davis L, Chang J, Lewis AJ.
    Agents Actions; 1985 Dec 15; 17(2):197-204. PubMed ID: 3938181
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.